Phase III Study To Evaluate Alirocumab in Patients With Hypercholesterolemia Not Treated With a Statin (ODYSSEY CHOICE II)

A phase 3 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 233 participants.

Also called NCT02023879

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; triple masking; primary purpose treatment
Phase
Phase 3
Enrolled
  • 233 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT02023879
  • EudraCT 2013-002659-14
Other papers using this trial's data
  • Efficacy and Safety of Alirocumab 150 mg Every 4 Weeks in Patients With Hypercholesterolemia Not on Statin Therapy: The ODYSSEY CHOICE II Study Journal of the American Heart Association, 2016-09-13 DOI, PubMed 27625344, PMC5079013 In the PMC Open Access subset under CC BY-NC.

Courtesy of the U.S. National Library of Medicine.

Start date
(registry gives no type) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Results first posted
(from the registry)
Countries
United States, Australia, Belgium, Canada, Denmark, Netherlands, New Zealand, Spain (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT02023879. Randomized; triple masking; primary purpose treatment. Start 2013-12-16 (registry gives no type); primary completion 2014-10-27 (actual). Results posted on 2017-03-15.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Phase III Study To Evaluate Alirocumab in Patients With Hypercholesterolemia Not Treated With a Statin (ODYSSEY CHOICE II)
Condition
Hypercholesterolemia
Intervention (Drug)
Alirocumab
Intervention (Drug)
Placebo (for Alirocumab)
Intervention (Drug)
Non-statin LMT
Intervention (Other)
Diet Alone
Lead sponsor
Sanofi (class: industry)
Collaborator
Regeneron Pharmaceuticals (class: industry)

Record details

Record id
cardio:ct-nct02023879
Content hash
ad946523d875fb7ac6e0f878a61df5ae3fa514ac1eb3a823c842e6c33fc88f2f